Evidence map›Paper›PMID 33107693›Full record

ArticleNeuropsychopharmacology reports2020

Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan.

Tatsushi Nagano, Sohei Kimoto, Katsuro Aso, Takashi Komori, Yasunari Yamaguchi, Kazuya Okamura, Noriya Yamamoto, Toshifumi Kishimoto

Open access · goldAbstract read
In one paragraph

Article in Neuropsychopharmacology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Tatsushi NaganoDepartment of Psychiatry, Fukko-kai Tarumi Hospital, Kobe, Japan.
Sohei KimotoDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan.ORCID 0000-0002-3148-690X
Katsuro AsoDepartment of Psychiatry, Fukko-kai Tarumi Hospital, Kobe, Japan.
Takashi KomoriDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan.
Yasunari YamaguchiDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan.
Kazuya OkamuraDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan.
Noriya YamamotoDepartment of Psychiatry, Fukko-kai Tarumi Hospital, Kobe, Japan.
Toshifumi KishimotoDepartment of Psychiatry, Nara Medical University School of Medicine, Kashihara, Japan.
Nara Medical University · JPKobe Kaisei Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimWe assessed the efficacy of buprenorphine replacement taper therapy in a psychiatric hospital in Japan.

methodsBased on the medical records, a retrospective analysis was performed to evaluate the outcomes of buprenorphine replacement taper therapy in 106 subjects with heroin dependence.

resultsWe found that replacement and taper therapy with buprenorphine could significantly reduce withdrawal symptoms during detoxification. In addition, the completion rate of detoxification was significantly improved and the length of hospital stay was significantly reduced relative to those who received conventional treatment without buprenorphine. However, the readmission rate increased after the introduction of detoxication therapy with buprenorphine.

conclusionThe present findings suggest not only the efficacy and safety of buprenorphine replacement and taper therapy, but also the requirement for maintenance therapy for individuals with heroin dependence.

Indexed as

AdultBuprenorphineFemaleHeroin DependenceHospitals, PsychiatricHumansInjections, IntramuscularJapanLength of StayMaleMiddle AgedNarcotic AntagonistsOpiate Substitution TreatmentRetrospective StudiesSubstance Withdrawal SyndromeBuprenorphineNarcotic AntagonistsbuprenorphineClinical Opiate Withdrawal Scaledetoxificationheroinopioid use disorder

Identifiers

PMID33107693
PMCPMC7722651
OpenAlexW3094438615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.